Regenxbio has a competitive advantage in the market with its proprietary NAV technology platform, based on AAV vectors, that is highly effective, efficient, and scalable. The recent Phase II trial on ...

A study on vector database and AI integration identifies unstable indexing, weak cross-modal fusion, and rigid resource ...

Researchers developed a gorilla adenovirus platform with inherent tumor selectivity, lung tropism, and large-gene capacity.

Demand for lentiviral vectors will continue to outstrip supply until the industry has access to more efficient, purpose-built manufacturing and bioprocessing technologies. The warning comes from ...

Introgen Therapeutic’s (Austin, TX) p53-based INGN 225 cancer vaccine yielded promising safety and efficacy results in a Phase II trial in advanced small cell lung cancer. The personalized therapeutic ...

SAN FRANCISCO--(BUSINESS WIRE)--Vector Capital (“Vector”), a leading private equity firm specializing in transformational investments in established technology businesses, today announced the ...

Based in San Francisco, Vector Capital invests in middle-market technology and technology-enabled businesses Vector was founded in 1997 Vector Capital has agreed to acquire San Francisco-based ...

Artificial intelligence-driven search and discovery startup Marqo.ai said today it has closed on an A$8 million (about $5.2 million USD) seed funding round. The lead investor in the company, ...

IonQ, a quantum computing technology company, has finalized the acquisition of quantum sensing firm Vector Atomic. IonQ said Tuesday the all-stock transaction enhances its position as a full-spectrum ...